You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TBPH Sale Disclosure
Farnum Rhonda · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$56.71K
Farnum Rhonda SVP, Comm & Medical Affairs
TBPH
Theravance Biopharma
TBPH
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
TBPH daily price context
Close on/before transaction
$17.04
Sep 15, 2026
First close after public filing
$17.02
Sep 18, 2026
Return after filing · so far
+0.06%
Through Sep 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 3,329 shares @ $17.03
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001898490-26-000014
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$226.79K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Theravance Biopharma, Inc. TBPH | Sale | Sep 15, 2026 | $113.4K |
| Theravance Biopharma, Inc. TBPH Current | Sale | Sep 15, 2026 | $56.71K |
| Theravance Biopharma, Inc. TBPH | Sale | Sep 15, 2026 | $56.69K |